Managing severe cancer pain: the role of transdermal buprenorphine: a systematic review

References

• HearnJHigginsonIJBrueraEDPortenoyRKCancer pain epidemiology: a systematic reviewCancer Pain, Assessment and ManagementCambridgeCambridge University Press2003
   Google Scholar
• van den Beuken-van EverdingenMHde RijkeJMKesselsAGSchoutenHCvan KleefMPatijnJPrevalence of pain in patients with cancer: a systematic review of the past 40 yearsAnn Oncol2007181437144917355955
   PubMed Web of Science ®Google Scholar
• DeandreaSMontanariMMojaLApoloneGPrevalence of undertreatment in cancer pain. A review of published literatureAnn Oncol2008191985199118632721
   PubMed Web of Science ®Google Scholar
• World Health OrganizationCancer Pain Relief2nd edGenevaW.H.O1996
   Google Scholar
• JacoxACarrDBPayneRNew clinical-practice guidelines for the management of pain in patients with cancerN Engl J Med19943306516557508094
   PubMed Web of Science ®Google Scholar
• SIGN: Scottish intercollegiate guideline networkControl of pain in patients with cancerA national clinical guideline SIGN publication number 44, June 2000
   Google Scholar
• HanksGDe ConnoFChernyNfor Expert Working Group of the Research Network of the European Association for Palliative CareMorphine and alternative opioids in cancer pain the EAPC recommendationsBr J Cancer20018458759311237376
   PubMed Web of Science ®Google Scholar
• SkaerTLTransdermal opioids for cancer painHealth Qual Life Outcomes200631424
   Google Scholar
• KressHGClinical update on the pharmacology, efficacy and safety of transdermal buprenorphineEur J Pain20091321923018567516
   PubMed Web of Science ®Google Scholar
• McQuayHJMooreRACowanALewisJWBuprenorphine kinetics in humansBuprenorphine: Combating Drug Abuse with a Unique OpioidNew YorkWiley-Liss1995137147
   Google Scholar
• WeinbergDSInturrisiCEReidembregBSublingual absorption of selected opioid analgesicsClin Pharmacol Ther1988443353422458208
   PubMed Web of Science ®Google Scholar
• GarrettERChandranVRPharmacokinetics of morphine and its surrogates: bioanalysis, solvolysis kinetics, solubility, pKa values and protein binding of buprenorphineJ Pharmaceut Sci198574515524
   PubMed Web of Science ®Google Scholar
• HuangPKehnerGBCowanAComparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonistJ Pharmacol Exp Ther200129768869511303059
   PubMed Web of Science ®Google Scholar
• CowanACowanALewisJWupdate on the general pharmacology of buprenorphineBuprenorphine: Combating Drug Abuse with a Unique OpioidNew YorkWiley-Liss19953147
   Google Scholar
• TraynorJRNahorskiSRmodulation by mu-opioid agonists of guanosine-5’-0-(3-(35S)thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cellsMol Pharmacol1995478488547723747
   PubMed Web of Science ®Google Scholar
• SelleyDALiuQChildersSRSignal transduction correlates of mu-opioid agonist intrinsic efficacy: receptor-stimulated [35S]GTP gamma S binding in mMOR-CHO cells and rat thalamusJ Pharmacol Exp Ther19982854965059580589
   PubMed Web of Science ®Google Scholar
• TollLBerzetei-GurskeIPPolgarWEStandard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medicationsNIDA Res Monogr19981784404669686407
   PubMedGoogle Scholar
• LeeKAkilHWoodsJHNovel binding properties of oripavines at a cloned mu-opioid receptorEur J Pharmacol199937832333010493109
   PubMed Web of Science ®Google Scholar
• RomeroDVPartillaJSZhengQXOpioid peptide receptor studies. Buprenorphine is a potent and selective mu/kappa antagonist in the [35S]-GTP-gamma-S functional binding assaySynapse199934839410502307
   PubMed Web of Science ®Google Scholar
• ZhuJLuoLYChenCActivation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligandsJ Pharmacol Exp Ther19972826766849262330
   PubMed Web of Science ®Google Scholar
• DahanAYassenARombergRBuprenorphine induces ceiling in respiratory depression but not in analgesiaBr J Anaesth20069662763216547090
   PubMed Web of Science ®Google Scholar
• RothmanRBCowanALewisJWBuprenorphine: a review of the binding literatureBuprenorphine: Combating Drug Abuse with a Unique OpioidNew YorkWiley-Liss19951929
   Google Scholar
• VilligerJWTaylorKMBuprenorphine: characteristics of binding sites in the rat central nervous systemLife Sci198129269927086276633
   PubMed Web of Science ®Google Scholar
• SidhuBSKhichySSinghKHComparative evaluation of intramuscular buprenorphine, pentazocine and nefopam in postoperative pain reliefJ Ind Med Assoc199391288289
   PubMedGoogle Scholar
• EvansHCEasthoperSETransdermal buprenorphineDrugs2003631999201012962515
   PubMed Web of Science ®Google Scholar
• JohnsonREFuadalaPJPayneRBuprenorphine: considerations for pain managementJ Pain Symptom Manage20052929739615781180
   PubMed Web of Science ®Google Scholar
• HigginsJPTGreenSCochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]The Cochrane Collaboration2008
   Google Scholar
• BöhmeKLikarREfficacy and tolerability of a new opioid analgesic formulation, buprenorphine transdermal therapeutic system (TDS) in the treatment of patients with chronic pain. A randomized, double-blind, placebo-controlled studyPain Clinic200315193202
   Web of Science ®Google Scholar
• RadbruchLVielvoye-KerkmeerABuprenorphine TDS: the clinical development- rationale and resultsJ Clin Pract Suppl20031331528
   Google Scholar
• RadbruchLBuprenorphine TDS: use in daily practice, benefits for patientsInt J Clin Pract Suppl2003133192212665120
   PubMedGoogle Scholar
• SittlRGriessingerNLikarRAnalgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, randomized, double-blind, placebo-controlled trialClin Ther20032515016812637117
   PubMed Web of Science ®Google Scholar
• SorgeJSittlRTransdermal buprenorphine in the treatment of chronic pain: results of a Phase III, multicenter, randomized, double-blind, placebo-controlled studyClin Ther2004261808182015639693
   PubMed Web of Science ®Google Scholar
• GriessingerNSittlRLikarRTransdermal buprenorphine in clinical practice- post-marketing surveillance study of 13,179 patientsCurr Med Res Opin2005211147115616083522
   PubMed Web of Science ®Google Scholar
• MurielCFaildeIMicòJANeiraMSanchez-MagroIEffectiveness and tolerability of the buprenorphine transdermal system in patients with moderate to severe chronic pain: a multicenter, open-label, uncontrolled, prospective, observational clinical studyClin Ther20052745146215922818
   PubMed Web of Science ®Google Scholar
• ApoloneGManganoSCompagnoniAfor Cancer Pain Outcome Research GroupA multidisciplinary project to improve the quality of cancer pain management in ItalyJ Ambulatory Care Manage20062933234116985391
   PubMedGoogle Scholar
• LikarRKayserHSittlRLong-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, follow-up study in patients from three short-term clinical trialsClin Ther20062894395216860176
   PubMed Web of Science ®Google Scholar
• MercadanteSFerreraPVillariPIs there a ceiling effect of transdermal buprenorphine? Preliminary data in cancer patientsSupport Care Cancer20071544144417106658
   PubMed Web of Science ®Google Scholar
• CambaMRodriguez-LopezMJMurielCBuprenorphine TDS in the treatment of chronic nociceptive, neuropathic and cancer-related painJ Appl Ther Res20076313
   Google Scholar
• FreyeEAnderson-HillemacherARitzdorfILevyJVOpioid rotation from high-dose morphine to transdermal buprenorphine (Transtec®) in chronic pain patientsPain Practice2007712312917559481
   PubMedGoogle Scholar
• LikarRLorenzVKorak-LeiteMKagerISittlRTransdermal buprenorphine patches applied in a 4-day regimen versus 3-day regimen: a single-site, phase III, randomized, open-label, crossover comparisonClin Ther2007291591160617919542
   PubMed Web of Science ®Google Scholar
• MercadanteSPorzioGFulfaroFSwitching from transdermal drugs: an observational “N of 1” study of fentanyl and burenorphineJ Pain Symptom Manage200753253817629666
   PubMed Web of Science ®Google Scholar
• PaceMCPassavantiMBGrellaEBuprenorphine in long-term control of chronic pain in cancer painFront Biosci2007121291129917127381
   PubMed Web of Science ®Google Scholar
• LikarRVadlauEMBreschanCKagerIKorak-LeiterMZiervogelGComparable analgesic efficacy of transdermal buprenorphine in patients over and under 65 years of ageClin J Pain20082453654318574363
   PubMed Web of Science ®Google Scholar
• PoulainPDenierWDoumaJEfficacy and safety of transdermal buprenorphine: a randomized, placebo-controlled trial in 289 patients with severe cancer painJ Pain Symptom Manage20083611712518411010
   PubMed Web of Science ®Google Scholar
• WirzSWittmannMSchenkMGastrointestinal symptoms under opioid therapy: a prospective comparison of oral-sustained release hydromorphone, transdermal fentanyl, and transdermal buprenorphineEur J Pain200810.1016/j.ejpain.2008.09.005
   Web of Science ®Google Scholar
• ApoloneGCorliONegriEManganoSMontanariMGrecoMTon behalf of the writing protocol committee and the Cancer Pain Outcome Research Study Group (CPOR SG) InvestigatorsEffects of transdermal buprenorphine on patients-reported outcomes in cancer patients. Results from the Cancer Pain Outcome Research (CPOR) Study GroupClin J PainIn press2009
   Web of Science ®Google Scholar
• HjermstadMJGibbinsJHaugenDFCaraceniALogeJHKaasaSfor EPCRC European Palliative Care Research CollaborativePain assessment tools in palliative care: an urgent need for consensusPalliat Med20082289590318799513
   PubMed Web of Science ®Google Scholar
• KaasaSLogeJHFayersPSymptom assessment in palliative care: a need for international collaborationJ Clin Oncol2008263867387318688054
   PubMed Web of Science ®Google Scholar
• ZeppetellaGWiffenPJBuprenorphine for cancer painCochrane Database of Systematic Reviews20074 Art. No: CD00676610.1002/14651858.CD006766
   Google Scholar
• ApoloneGCorliOCaraceniAfor Cancer Pain Outcome Research Study Group (CPOR SG) InvestigatorsPattern and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research Study Group (CPOR SG)Br J Cancer20091001566157419401688
   PubMed Web of Science ®Google Scholar